International Lymphoma Epidemiology Consortium
The InterLymph Consortium, or formally the International Consortium of Investigators Working on Non-Hodgkin's Lymphoma Epidemiologic Studies, is an open scientific forum for epidemiologic research in non-Hodgkin's lymphoma. Formed in 2001, the Consortium is a group of international investigators who have completed or have ongoing case-control studies and who discuss and undertake research projects that pool data across studies or otherwise undertake collaborative research.
Support for logistical needs of the Consortium is provided by NCI's Division of Cancer Epidemiology and Genetics (DCEG), which is the intramural (in-house) research component of the Institute, and the Epidemiology and Genomics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS), which manages the epidemiology grant program for the Institute; the International Agency for Research on Cancer (IARC); and the Leukaemia Research Fund. Some investigators within the Consortium also have grant support for research projects.
InterLymph is led by a Coordinating Committee, which has a rotating membership. View list of current Coordinating Committee members.
The Consortium consists of five working groups focused on genetics, Hodgkin's lymphoma, immunity and infection, lifestyle and environment, and pathology and survival. View a list of contacts for each of the working groups.
Within the scope defined by its Mission, the objectives of InterLymph are to expand knowledge of lymphoma etiology and survival through:
- Fostering collaborations between researchers in different countries;
- Providing a framework for the efficient conduct and publication of original data meta-analyses of relevant studies;
- Providing a forum and framework for discussion, development and pursuit of new research directions; and
- Supporting the development of early career researchers.
InterLymph welcomes researchers interested in pursuing epidemiologic or etiological studies of non-Hodgkin and/or Hodgkin lymphoma that would allow contribution to and/or participation in pooled studies.
If you are a researcher who is interested in becoming an InterLymph member, please contact Aaron Norman to request information about membership.
InterLymph investigators have jointly published more than 20 scientific articles since 2005.
- Martha Linet, M.D., M.P.H., Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI
- Rao L. Divi, Ph.D., Epidemiology and Genomics Research Program, DCCPS, NCI
- Aaron Norman, M.P.H., Administrative Services - Research, Mayo Clinic